In a transaction officially set to close later this month, Syngene International Limited, a contract research, development, ...
The Baltimore Biologics Drug Substance facility will serve customers across human and animal health market segments.
Peter Bains, CEO Designate, Syngene International , said, “With one of the largest biologics R&D teams and commercial scale manufacturing capabilities in both India and the USA, we now offer a ...
Peter Bains, CEO Designate, Syngene International Ltd., said, "With one of the largest biologics R&D teams and commercial scale manufacturing capabilities in both India and the USA, we now offer a ...
Peter Bains, CEO Designate, Syngene International Ltd., said, “With one of the largest biologics R&D teams and commercial scale manufacturing capabilities in both India and the USA, we now offer a ...
Peter Bains, CEO Designate, Syngene International Ltd., said, "With one of the largest biologics R&D teams and commercial scale manufacturing capabilities in both India and the USA, we now offer a ...